-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND REACHES KEY CLINICAL TRIAL MILESTONE AS DSMB UNANIMOUSLY CLEARS PROGRESSION IN AUD STUDY

Reuters·08/06/2026 12:00:04

Please log in to view news